Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Combretastatin A1 diphosphate

EU orphan designation number: EU/3/15/1587   
Active ingredient: Combretastatin A1 diphosphate
Indication: Treatment of acute myeloid leukaemia
Sponsor: Diamond ROC EOOD
Bul. Gen. Totleben 53-55, Office 311, Kriva Reka, Sofia 1606, България

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/12/2015 Orphan designation EMA/OD/144/15 (2015)9509 of 14/12/2015
18/03/2019 Transfer of orphan designation EMA/OD/0000003811 (2019)2149 of 14/03/2019